| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | 1,410,689 | 22,500,000 | 19.95% | ||
| 2 | GLOBAL BLOOD THERAPEUTICS IN COM | 460,000 | 14,872,000 | 13.19% | ||
| 3 | ALDER BIOPHARMACEUTICALS INC | 229,895 | 7,593,000 | 6.73% | ||
| 4 | EPIZYME INC COM | 461,651 | 7,396,000 | 6.56% | ||
| 5 | ZAFGEN INC COM | 1,099,700 | 6,917,000 | 6.13% | ||
| 6 | AIMMUNE THERAPEUTICS INC COM | 355,020 | 6,550,000 | 5.81% | ||
| 7 | REGULUS THERAPEUTICS INC | 718,997 | 6,270,000 | 5.56% | ||
| 8 | AERIE PHARMACEUTICALS INC | 232,757 | 5,668,000 | 5.03% | ||
| 9 | Orexigen Therapeutics, Inc. | 3,000,000 | 5,160,000 | 4.58% | ||
| 10 | ACCELERON PHARMA | 100,000 | 4,876,000 | 4.32% | Put | |
| 11 | Intersect ENT Inc | 200,000 | 4,500,000 | 3.99% | ||
| 12 | NEURODERM LTD | 261,945 | 4,466,000 | 3.96% | ||
| 13 | LIPOCINE INC NEW | 330,000 | 4,267,000 | 3.78% | ||
| 14 | AKARI THERAPEUTICS PLC | 263,921 | 3,827,000 | 3.39% | ||
| 15 | ACCELERON PHARMA | 50,047 | 2,440,000 | 2.16% | ||
| 16 | DYAX CORP COM CVR | 55,900 | 2,103,000 | 1.87% | Call | |
| 17 | REGENXBIO INC COM | 100,000 | 1,660,000 | 1.47% | ||
| 18 | DIMENSION THERAPEUTICS INC COM | 98,297 | 1,109,000 | 0.98% | ||
| 19 | IMMUNOGEN INCORPORATED | 42,815 | 581,000 | 0.52% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-081047, filed 2016.02.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
